Tax Dodger Apple Te...
Health Care: Drugs
Sinovac Biotech Ltd. (SVA: NASDAQ)
$3.41 0.11 | 3.33%
05/21/13 - 02:24 PM ET
121.46K / 491.50K
Vol / Avg. Vol:3.30 / 3.30
Open / Prev. Close:3.30 - 3.44
Today's Range:1.66 - 5.09
52 Wk Range:2.87%
Performance YTD:TheStreet Rating:
Portfolios with SVA
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- Contributor7 Earnings Stocks to Watch
- Contributor5 Stocks Under-$10 Setting ...
- Usermon1
- UserSUPRATRADE Top 10 U.S.-List...
- Usertradee Portfolio 1
- UserMtsuneishi Portfolio 1
- Userfrychef's finest
- UserTachyon1
Latest SVA Headlines from TheStreet
- 5 Stocks Poised for Breakouts 04.05.13 | 02:04 pm
- 5 Stocks Under $10 Triggering Breakouts 03.14.13 | 01:03 pm
- Sinovac Biotech Ltd. Stock Downgraded (SVA) 11.19.12 | 04:11 am
- Sinovac Biotech Ltd. Stock Upgraded (SVA) 10.16.12 | 05:10 am
- 4 Biotech Stocks Under $10 Soaring Higher 09.25.12 | 02:09 pm
- Sinovac Biotech's CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.15.12 | 11:08 am
- Sinovac Biotech Ltd. Stock Downgraded (SVA) 05.17.12 | 05:05 am
- Sinovac Biotech Ltd. Stock Upgraded (SVA) 04.02.12 | 04:04 am
- Sinovac Biotech Ltd. Stock Downgraded (SVA) 11.16.11 | 05:11 am
- 7 Earnings Reports to Watch Next Week 11.11.11 | 09:11 am
Press Releases for SVA
- Sinovac To Host Conference Call To Report First Quarter 2013 Unaudited Financial Results - PR Newswire 05.17.13 | 05:05 am
- Sinovac Appoints Ernst & Young Hua Ming Llp China As External Auditor - PR Newswire 05.15.13 | 06:05 am
- Sinovac Presents At The UBS Global Healthcare Conference In May 2013 - PR Newswire 05.14.13 | 06:05 am
- Sinovac Files Annual Report On Form 20-F - PR Newswire 04.30.13 | 07:04 am
- Sinovac EV71 Vaccine Phase III Top-Line Results Presented At 13th Annual World Vaccine Congress & Expo - PR Newswire 04.18.13 | 07:04 am
- Sinovac Receives Commercial Approval In Mexico For Seasonal Flu Vaccine - PR Newswire 04.18.13 | 07:04 am
- Sinovac Schedules Conference Call And Webcast For Fourth Quarter And Full Year Unaudited Financial Results - PR Newswire 04.02.13 | 06:04 am
- Sinovac Reports Preliminary Top-Line Results From Phase III Clinical Trial For EV71 Vaccine Candidate Against Hand, Foot And Mouth Disease - PR Newswire 03.14.13 | 06:03 am
- Sinovac To Host Conference Call To Report Third Quarter 2012 Unaudited Financial Results - PR Newswire 10.29.12 | 08:10 am
- Sinovac Awarded Tenders In Beijing And Shanghai To Supply Inactivated Hepatitis A Vaccine Healive® Under Expanded Immunization Program - PR Newswire 09.25.12 | 08:09 am
Partner Headlines for SVA
- 3 Vaccine Companies With Upcoming Catalysts - Seeking Alpha 09.09.12 | 08:09 am
- China Biotech Week in Review: Deals and Transactions, Trials and Approvals - Seeking Alpha 05.29.11 | 08:05 am
- China Biotech in Review: Thermo Fisher Scientific Displays Increased Commitment - Seeking Alpha 03.06.11 | 08:03 am
- 'Guru' Report Card: Grading the Picks of the Market's Biggest Names - Seeking Alpha 12.03.10 | 07:12 am
- Sinovac Biotech Upgraded at Brean Murray - Benzinga 11.11.10 | 09:11 am
- China Biotech Week in Review: Upping the Stakes - Seeking Alpha 08.22.10 | 08:08 am
- UPDATE 1-Sernova diabetes control device shows promise in pigs - Reuters 07.12.10 | 07:07 am
- Sinovac Wins Order for China’s National Immunization Program - Seeking Alpha 06.01.10 | 02:06 pm
- China Biotech Week in Review: IPO, Deals and Trials - Seeking Alpha 05.09.10 | 10:05 am
- Sinovac Hopes to Begin Mumps Vaccine Trial - Seeking Alpha 05.06.10 | 12:05 pm
